Research data is only as reliable as the materials it was generated with. A study using misidentified or degraded compound produces results that mean nothing, and the failure is often invisible in the data itself, which is what makes it genuinely dangerous.
Verification is therefore not an optional diligence step. Here is what to check, what the documentation actually tells you, and where the common gaps are.
Start With the Certificate of Analysis
A certificate of analysis, or COA, is a document produced by an analytical laboratory recording test results for a specific batch of material.
The word specific is doing significant work in that sentence. A COA applies to one batch, identified by a batch or lot number, not to a product line generally. A certificate for a different batch of the same product describes material you do not have.
The first check is therefore the simplest: does the batch number on the certificate match the batch number on your vial? If a supplier cannot provide a batch-matched certificate, the documentation is not verification.
Identity: Mass Spectrometry
The first question a COA answers is whether the material is the compound it claims to be. This is typically established through mass spectrometry.
Mass spectrometry measures molecular weight with high precision. Every peptide has an expected molecular weight determined by its amino acid sequence. If the measured value matches the theoretical value, that constitutes strong evidence the correct molecule is present.
On a certificate you should see both figures: theoretical or expected molecular weight, and observed or measured. These should align closely. A meaningful discrepancy indicates something other than the labeled compound, and is the single clearest red flag available.
Purity: HPLC
The second question is what proportion of the material is the intended compound rather than impurities, synthesis byproducts, or degradation products. High-performance liquid chromatography, or HPLC, is the standard method.
HPLC separates the components of a mixture and quantifies each. Results are expressed as a percentage, and research-grade material generally reports 98 percent or higher.
Many certificates include the chromatogram itself, a graph showing peaks corresponding to detected components. You do not need to interpret it in detail. Its presence is meaningful in itself, because it means the laboratory is showing its work rather than asserting a number.
What the Purity Figure Does Not Cover
This is where a lot of misunderstanding sits, and understanding it prevents overinterpreting a number that looks precise.
HPLC purity refers to the proportion of peptide-related material that is the target peptide. It typically does not account for non-peptide content: residual water, salts, or counterions remaining from synthesis.
The practical consequence is that a vial labeled with a given peptide mass may contain somewhat less actual peptide than stated, depending on manufacturing and characterization methods. This is a known convention in how peptide purity is reported rather than misconduct, but it matters when precise quantities affect a protocol.
Third-Party Versus In-House Testing
Testing performed by a laboratory independent of the manufacturer carries more weight than in-house analysis, for the obvious reason that it removes the conflict of interest in a supplier verifying its own material.
Certificates should identify the testing laboratory. Where a supplier performs its own analysis exclusively, that is not automatically disqualifying, but it is worth knowing, and it should factor into how much weight the documentation carries.
Common Red Flags
Several patterns suggest documentation deserves closer scrutiny.
Certificates with no batch number, or a batch number that does not match your material, verify nothing. Purity figures reported without specifying the analytical method are less meaningful than figures tied to a stated HPLC protocol. Missing testing dates leave you unable to assess how current the analysis is.
Generic certificates appearing identical across different batches warrant particular attention, since genuine batch testing produces batch-specific results with natural minor variation. And a supplier unwilling to provide documentation at all, for material sold on the basis of purity claims, has answered the question in its own way.
Verification Does Not End at Purchase
Documented purity establishes a baseline. Maintaining it is a separate matter, and it is where a surprising amount of material quality is lost.
Peptides degrade through repeated freeze-thaw cycles, exposure to light for compounds sensitive to it, and improper temperature during storage or transit. None of this is necessarily visible on inspection.
Standard practice addresses most of it: aliquot reconstituted material into working volumes rather than drawing repeatedly from a single vial, store according to compound-specific requirements rather than a general rule, and reconstitute with appropriate diluent. For most lyophilized peptides that means bacteriostatic water, whose benzyl alcohol preservative permits multiple withdrawals from a single vial without contamination, though some compounds require different diluents.
Shipping Conditions
Material can arrive already compromised, and this is easy to overlook when assessing a supplier.
Temperature-controlled packaging matters for compounds sensitive to heat, and transit times matter correspondingly. A supplier's shipping practices are part of quality control rather than a separate logistics question, and worth asking about directly before ordering.
A Practical Checklist
Before ordering: confirm the supplier provides batch-specific certificates, confirm testing is performed by an independent laboratory, and confirm shipping conditions suit the compounds involved. On receipt: match the batch number, check observed against theoretical molecular weight, confirm purity meets your threshold, and note the testing date. Suppliers of research peptides operating to a reasonable standard should provide all of this without friction, and reluctance at any step is itself informative.
None of this is complicated. It is simply the difference between data you can build on and data you cannot, which is a distinction worth a few minutes per order.
Comments